<p>A. Schematic positioning of epitopes for antibodies employed in these studies. 2B7 (recognizing the N17 domain), MW1 and 3B5H10 (specific for the polyQ region), 4C9 (recognizing an epitope within the PRR region) and 2166 (specific for an epitope around residue K444). B. Coomassie gel staining of the N548 hrHTT proteins, 5 µg of each protein bearing the indicated polyQ repeat length was loaded on the gel. C. Western blot of N548 hrHTT proteins employed in the TR-FRET analyses, probed with 2B7, MW1 and an antibody specific for a domain within the PRR region (4C9). 0.25 µg of protein bearing the indicated polyQ repeat length.</p
<p>(A) Schematic representation of the full length CDV-H-protein (H-wt) and a derivative soluble for...
An important issue for the performance and specificity of an antibody is the nature of the binding t...
<p>Titrations of humanized variants were competed against a fixed concentration (35 ng/ml) of biotin...
<p>(A) Diagram representing antibody epitopes on human HTT protein (relative to GenBank accession CA...
<p>(A) The domain structure of HtrA1, HtrA3, HtrA4 and HtrA2. (B) The domain structure of HtrA3-L an...
a<p>Epitope on human PrP.</p>b<p>Repeat region aa 59–65, 67–73, 75–81, 83–89. Epitope reference: SAF...
<p>Surface structure models of hemagglutinin (HA) A(H1N1)pdm09 (PDB structure 3AL4) showing the two ...
<p>Peptide sequences for epitope screening were selected from HA1 polypeptide region of A/Vietnam/12...
<p>(A) Western blotting analysis of hH5M9 with HA. Purified A/Anhui/1/05 HA was applied to SDS-PAGE ...
<p>(A) Schematic structures of the vaccine antigen (Trx-His-IL-33), the carrier protein (His-Trx) an...
<p>A total of 44 antigenic sites were identified from all the E6 proteins. Residues shared by both B...
<p>(A) Percent antigen specific CD8+ T-cell recognizing the A*02:01 restricted epitopes (AML(G/<b>D<...
<p>The antisera collected from mice immunized with (A) WT-Tat or (B) PADRE-CRD proteins were diluted...
<p>A. Each of twenty-seven peptides that covered the full length of the F1-antigen were used to coat...
<p>HTT (1–573) Q23 and HTT (1–573) Q73 large fragment and full length wild type (Q17) and mutant (Q4...
<p>(A) Schematic representation of the full length CDV-H-protein (H-wt) and a derivative soluble for...
An important issue for the performance and specificity of an antibody is the nature of the binding t...
<p>Titrations of humanized variants were competed against a fixed concentration (35 ng/ml) of biotin...
<p>(A) Diagram representing antibody epitopes on human HTT protein (relative to GenBank accession CA...
<p>(A) The domain structure of HtrA1, HtrA3, HtrA4 and HtrA2. (B) The domain structure of HtrA3-L an...
a<p>Epitope on human PrP.</p>b<p>Repeat region aa 59–65, 67–73, 75–81, 83–89. Epitope reference: SAF...
<p>Surface structure models of hemagglutinin (HA) A(H1N1)pdm09 (PDB structure 3AL4) showing the two ...
<p>Peptide sequences for epitope screening were selected from HA1 polypeptide region of A/Vietnam/12...
<p>(A) Western blotting analysis of hH5M9 with HA. Purified A/Anhui/1/05 HA was applied to SDS-PAGE ...
<p>(A) Schematic structures of the vaccine antigen (Trx-His-IL-33), the carrier protein (His-Trx) an...
<p>A total of 44 antigenic sites were identified from all the E6 proteins. Residues shared by both B...
<p>(A) Percent antigen specific CD8+ T-cell recognizing the A*02:01 restricted epitopes (AML(G/<b>D<...
<p>The antisera collected from mice immunized with (A) WT-Tat or (B) PADRE-CRD proteins were diluted...
<p>A. Each of twenty-seven peptides that covered the full length of the F1-antigen were used to coat...
<p>HTT (1–573) Q23 and HTT (1–573) Q73 large fragment and full length wild type (Q17) and mutant (Q4...
<p>(A) Schematic representation of the full length CDV-H-protein (H-wt) and a derivative soluble for...
An important issue for the performance and specificity of an antibody is the nature of the binding t...
<p>Titrations of humanized variants were competed against a fixed concentration (35 ng/ml) of biotin...